Nanodem recently presented work showing progress in real time immunosuppressant monitoring using MicroEye®.
The management reporting and assessment of glycemic control lacks standardisation.
Today, patients undergoing routine treatments, such as cancer treatment, organ transplantation and hip and knee replacements, are routinely given antibiotics to prevent infection during therapy.
Third party study confirms use of MicroEye® to optimise Continuous Glucose Monitoring in Hospital.
The neat, stylish ContinuMon® system is designed to provide the external monitoring and sensing system to compliment Probe’s patented MicroEye® continuous sampling technology.